TME Pharma N.V. reported earnings results for the half year ended June 30, 2021. For the half year, the company reported net loss was EUR 6.76 million compared to EUR 5.92 million a year ago. Basic loss per share from continuing operations was EUR 11 compared to EUR 26 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2485 EUR | +2.05% | -0.20% | +8.04% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.04% | 7.61M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ALTME Stock
- News TME Pharma N.V.
- TME Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2021